【レポートの概要（一部）】
1. Report Overview
1.1 Leading Contract Manufacturing Organisations (CMOs) Overview
1.2 Benefits of This Report
1.3 How This Report Delivers Information
1.4 Main Questions This Report Answers
1.5 Who is This Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Related Reports
1.9 About Visiongain
2. Introduction to Pharmaceutical Contract Manufacturing, 2015
2.1 What Services Do Contract Manufacturers Offer?
2.1.1 Why Do Firms Outsource Manufacturing?
2.1.2 What Is Driving Demand for Contract Manufacturing Services?
2.2 The Pharmaceutical Contract Manufacturing Market, 2014
2.2.1 Where is Supply and Demand Highest for Contract Manufacturing Services?
2.3 Outlook for the Pharmaceutical Contract Manufacturing Market 2015-2025
2.4 Driving and Restrictive Forces for Pharmaceutical Contract Manufacturing, 2015-2025
2.4.1 Pharmaceutical Contract Manufacturing: Market Drivers 2015-2025
2.4.2 Pharmaceutical Contract Manufacturing: Market Restraints 2015-2025
2.5 Who Are the Leading Pharmaceutical Contract Manufacturers in 2014?
3. Leading CMOs in North America
3.1 Catalent Pharma Solutions- One of the World’s Leading CMO
3.1.1 Catalent: Manufacturing Services and Capabilities
3.1.2 Divisional Segmentation – Breaking Down Catalent’s Service
3.1.3 Catalent Pharma’s Revenue Growth, 2010-2014
3.1.4 Sustained Growth in Oral Products: Catalent Pharma’s Divisional Performance, 2010-2014
3.1.5 Catalent Is Expanding its Oral Technologies Division
3.1.6 Quadrupling Biopharmaceutical Manufacturing Capacity
3.1.7 Expansion of Packaging Services in Asia-Pacific and Europe: 2015
3.1.8 Adding New Early-Stage Development Services
3.1.9 Expansion in Japan – Growth Prospects for Catalent
3.1.10 New Business Contracts 2014-2015
3.1.11 Catalent New Products Launch
3.1.12 Catalent: Opportunities for Growth 2015-2025
3.1.13 Catalent: Mild Growth in Revenue, 2015-2025
3.2 Patheon – One of The Top 3 CMOs
3.2.1 Patheon – Global leader in Pharmaceutical Development Services
3.2.2 Contract Manufacturing Services at Patheon
3.2.3 Steady Revenue Growth 2010-2014
3.2.4 DPx Holdings: Developments
3.2.5 Adding New Formulations and Formulation Development Services
3.2.6 Reassessing Manufacturing Capacity
3.2.7 Expanding Services Through Acquisition, 2015
3.2.8 Patheon: SWOT Analysis 2015-2025
3.2.9 Patheon: Contract Manufacturing Revenue Forecast 2015-2025
3.3 Baxter BioPharma Solutions
3.3.1 Baxter BioPharma is the Global Leader in Sterile Fill and Finish
3.3.2 Historic Revenue Performance 2010-2014
3.3.3 Baxter BioPharma SWOT Analysis 2015-2025
3.3.4 Baxter BioPharma Revenue Forecast 2015-2025
3.4 AbbVie Contract Manufacturing
3.4.1 AbbVie Offers Full-Service Contract Manufacturing
3.4.2 Expanding and Adding New Services: 2013-2014
3.4.3 AbbVie Contract Manufacturing: Revenue 2011-2014
3.4.4 Biologics and HPAPIs Are an Opportunity for Growth 2015-2025
3.4.5 AbbVie Contract Manufacturing Revenue Forecast 2015-2025
3.5 Pfizer CentreSource
3.5.1 Pfizer CentreSource: Historic Revenue Performance, 2010-2014
3.5.2 Will Pfizer Divest CentreSource?
3.5.3 Outlook for CentreSource: Revenue Forecast 2015-2025
4. Leading European Contract Manufacturing Organisations
4.1 Lonza
4.1.1 Lonza Is a Leader in Biologics Manufacturing
4.1.2 Lonza Contract Manufacturing and Development: 2010-2014
4.1.3 Investing in Advanced Biological Drug Sectors
4.1.4 The Promise of Antibody-Drug Conjugates (ADCs)
4.1.5 The Regenerative Medicine Future in Japan
4.1.6 Lonza: SWOT Analysis 2015-2025
4.1.7 Biologics and Efficiency Savings Will Drive Growth in Revenue and Operating Profit for Lonza 2015-2025
4.2 Evonik Degussa
4.2.1 Investing in API and Drug Delivery Services
4.2.2 Moderate Growth in Pharmaceutical Manufacturing Services, 2010-2014
4.2.3 Evonik Is a HPAPI Specialist
4.2.4 Evonik Continues to Grow Across All Segments
4.2.5 How Can Evonik Expand in the Pharmaceutical Contract Manufacturing Market?
4.2.6 Evonik Degussa: Revenue Forecast 2015-2025
4.3 Royal DSM – The World’s Leading CMO
4.3.1 Amplified Revenue Growth in Pharma Manufacturing 2010-2014
4.3.2 DSM Pharmaceuticals Products: Manufacturing Services 2010-2014
4.3.3 DSM Sinochem Pharmaceuticals: A World Leader in Antibacterial Manufacturing
4.3.4 DPx Holdings: A New Pharma Leader
4.3.5 Investing in Biopharma Manufacturing
4.3.6 Expanding API Manufacturing
4.3.7 Generics and Biologics Are an Opportunity for Growth, 2014-2025
4.3.8 DSM Pharmaceuticals Products: Revenue Forecast 2015-2025
4.4 Boehringer Ingelheim Contract Manufacturing
4.4.1 Expanding Biopharmaceuticals Manufacturing Services in China
4.4.2 Production Through to Fill and Finished Biopharmaceuticals
4.4.3 A Track Record of Production for 29 Biopharma Products
4.4.4 Increasing Revenue from Contract Manufacturing, 2010-2014
4.4.5 Pulling Out of Small Molecule API Manufacturing
4.4.6 Expanding through New Services
4.4.7 Boehringer Ingelheim Biopharmaceuticals: Opportunities for Growth 2015-2025
4.4.8 Boehringer Ingelheim: Revenue Forecast 2015-2025
4.5 Fareva
4.5.1 Fareva Has 35 Years’ Manufacturing Experience
4.5.2 Revenue Growth through Acquisitions: 2010-2014
4.5.3 Fareva SWOT Analysis: 2015
4.5.4 Fareva Revenue Forecast: 2015-2025
4.6 Aenova Group
4.6.1 Acquisition of Haupt Creates European CMO Giant
4.6.2 Aenova’s Ever Expanding Manufacturing Capacity
4.6.3 Aenova’s Revenue 2010-2014: Organic Growth and Acquisitions
4.6.4 Aenova’s Competitive Position in the Contract Manufacturing Market: SWOT Analysis 2015
4.6.5 Becoming a Leading Contract Manufacturer: Aenova Revenue Forecast 2015-2025
4.7 Famar
4.7.1 Famar Is an Expert in Lyophilisation
4.7.2 Sustained Growth in Famar’s Revenue: 2010-2014
4.7.3 Expanding European Operations
4.7.4 Further Site Acquisitions Are an Opportunity for Growth 2015-2025
4.7.5 How Will Famar Perform 2015-2025?
4.8 Vetter Pharmaceutical
4.8.1 Vetter is an Injectable Manufacturing Specialist
4.8.2 Rapidly Growing Revenue in the US and Germany: 2010-2014
4.8.3 Services, Collaborations and Differentiating Factors
4.8.4 Expanding Services in US and Asia
4.8.5 Biologics Are an Opportunity for Growth for Vetter 2015-2025
4.8.6 Vetter Outlook: Revenue Forecast 2015-2025
4.9 Almac Group
4.9.1 Almac’s Manufacturing Services
4.9.2 Almac Outpaces the Market: 2011-2014
4.9.3 Almac Adding Capacity Globally
4.9.4 New Services Added 2012-2015
4.9.5 Almac Group: Contract Manufacturing Market Outlook 2015-2025
4.9.6 How Will Almac Group Perform 2015-2025?
4.10 Delpharm
4.10.1 Finished Dosage Form Manufacturing for Developed Markets
4.10.2 Delpharm: Rapid Revenue Growth Via Acquisitions, 2010-2014
4.10.3 Delpharm: Outlook and Prospects for Growth 2015-2025
4.10.4 Generics Will Drive Revenue Growth for Delpharm 2015-2025
4.11 Siegfried
4.11.1 Siegfried’s Acquisitions, 2010-2014
4.11.2 Expanding Siegfried’s Manufacturing Footprint Globally
4.11.3 Expanding High Potency API Capabilities
4.11.4 Siegfried: Financial Performance 2010-2014
4.11.5 Siegfried’s Characteristics within the Contract Manufacturing Market: SWOT Analysis 2015
4.11.6 Continued Revenue Growth for Siegfried 2015-2025
4.12 Corden Pharmaceutical
4.12.1 CordenPharma Service Division
4.12.2 CordenPharma Emerging in the API Market
4.12.3 Investments in Highly Potent Capabilities
4.12.4 CordenPharma: SWOT Analysis 2015-2025
4.13 Recipharm
4.13.1 Contract Development and Manufacturing Services
4.13.2 Recipharm: Financial Performance 2010-2014
4.13.3 Recipharm Invests in Facility Expansion
4.13.4 Recipharm Growing in Development & Technology Market through Acquisitions
4.13.5 Recipharm: Opportunities for Growth 2015-2025
4.13.6 Outlook for Recipharm: Revenue Forecast 2015-2025
4.14 Aesica Pharmaceuticals
4.14.1 Aesica Manufactures APIs and Finished Dosage Forms
4.14.2 Acquisitions Drive Revenue Growth but Operational Margins Have Declined, 2010-2014
4.14.3 Partnering with Academia for Innovative Solutions
4.14.4 Growth through Acquisitions and Internal Expansion
4.14.5 Aesica: Opportunities for Expansion 2015-2025
4.14.6 Forecast Aesica Financial Performance, 2015-2025
5. Leading Japanese Pharma Contract Manufacturing Organisations
5.1 Nipro Corporation: Japan’s Leading CMO
5.1.1 Nipro Pharmaceutical Contract Manufacturing Capabilities
5.1.2 Nipro: Decline in Revenue But Increasing Operating Profits 2010-2014
5.1.3 Biosimilars and Anti-Cancer Drugs Are Opportunities for Future Growth: SWOT Analysis 2015
5.1.4 Nipro Revenue and Profitability Forecast 2015-2025
5.2 Daito Pharmaceutical
5.2.1 Daito Has a Portfolio of More than 30 APIs
5.2.2 Rapid Growth in Revenue and Operational Profit: Daito Financial Performance 2010-2014
5.2.3 Daito Is Well-Placed for Asian Market Growth – SWOT Analysis 2015-2025
5.2.4 Sustained Growth in Revenue and Operating Profit for Daito, 2015-2025
6. Leading Developed-Market API Specialists
6.1 Teva API
6.1.1 API Manufacturing Services
6.1.2 Teva API: Financial Performance 2010-2014
6.1.3 Building a Footprint in Mexico, India and China
6.1.4 Teva API: SWOT Analysis 2015
6.1.5 Outlook for Teva API: Revenue Forecast 2015-2025
6.2 Esteve Química
6.2.1 Esteve Química Manufactures APIs for Developed and Emerging Markets
6.2.2 Expanding in The US, 2015
6.2.3 Esteve Química: SWOT Analysis 2015-2025
6.3 Euticals
6.3.1 Euticals Manufactures More than 200 APIs
6.3.2 Acquisitions Drive Growth 2010-2014
6.3.3 Adding Capacity for Finished Dosage Forms
6.3.4 Asian Expansion Is an Opportunity for Growth 2015-2025
6.3.5 Euticals: Revenue Forecast 2015-2025
7. Leading Chinese Pharmaceutical Contract Manufacturers
7.1 Zhejiang Hisun Pharmaceutical
7.1.1 API Manufacturing for Markets Worldwide
7.1.2 Zhejiang Hisun’s Rapid Growth in API Revenue Grows, 2010-2014
7.1.3 Moving Into International Drug Marketing
7.1.4 Zhejiang Hisun: Opportunities for Growth 2015-2025
7.1.5 Zhejiang Hisun: Strong API Revenue Growth 2015-2025
7.2 Zhejiang Huahai Pharmaceuticals
7.2.1 Zhejiang Huahai Is a Market Leader Within The Antihypertensive API Market
7.2.2 Zhejiang Huahai: Contract Manufacturing Performance 2010-2014
7.2.3 Expanding in the US Generic Drugs Market
7.2.4 Zhejiang Huahai: SWOT Analysis, 2015
7.2.5 Zhejiang Huahai: Revenue Forecast, 2015-2025
7.3 Shandong Xinhua Pharmaceutical
7.3.1 Experience in APIs and Finished Dosage Forms
7.3.2 Shandong Xinhua: Strong Revenue Growth 2010-2014
7.3.3 Growing through Joint Ventures
7.3.4 Looking to Expand in the US and EU 2015-2025
7.3.5 Shandong Xinhua Pharmaceutical: Revenue Forecast 2015-2025
8. Leading Indian Pharmaceutical Contract Manufacturers
8.1 Aurobindo Pharma
8.1.1 API Manufacturing Services
8.1.2 Aurobindo Pharma: Steady Revenue Growth 2010-2014
8.1.3 Aurobindo Expanding Outside of Antibacterials
8.1.4 Aurobindo: Opportunities for Expansion 2015-2025
8.1.5 How Will Aurobindo’s Contract Manufacturing Division Perform 2015-2025?
8.2 Divis Laboratories
8.2.1 Divis Laboratories and the Contract Manufacturing Industry
8.2.2 Divis Laboratories: A Rapidly Growing CMO, 2010-2014
8.2.3 Divis Laboratories: API Manufacturing Outlook 2015-2025
8.2.4 Divis Laboratories: API Manufacturing Revenue Forecast, 2015-2025
8.3 Dr. Reddy’s Laboratories
8.3.1 API and FDF Manufacturing Services
8.3.2 Dr. Reddy’s PSAI: Strong Revenue Growth 2010-2014
8.3.3 Advancing in Complex Drug Manufacturing
8.3.4 Expanding in the European Manufacturing Market
8.3.5 Dr. Reddy’s PSAI Division: Revenue Forecast 2015-2025
9. Research Interviews from Our Industry Survey
9.1 Dr Michael Quirmbach, Vice President, Global Sales & Marketing, CPI, Corden Pharma
9.2 Mrs Marianne Spaene, Executive Vice President, Global Head Business Development, Sales and Marketing, Siegfried
9.3 Dr Prabuddha Kundu, Cofounder & Executive Director, PREMAS Biotech
10. Conclusions of the Study
10.1 What Has Driven Growth for CMO Market Leaders in Recent Years?
10.2 Strategies for Growth: Prospects For Leading CMOs, 2015-2025
10.3 High Demand for Biopharmaceutical Manufacturing Services
10.4 Investing in Novel Technologies
10.5 Outlook for API Manufacturers
【レポート販売概要】
■ タイトル：世界のトップ30医薬品製造受託機関（CMO）■ 英文：Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) – Market, Industry, Trends, Technologies and Prospects 2015-2025
■ 発行日：2015年9月
■ 調査会社：visiongain
■ 商品コード：VGAIN5100108
■ 調査対象地域：グローバル
- 不応性慢性リンパ性白血病：グローバル臨床試験レビュー（2014年上半期）Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014" provides data on the Refractory Chronic Lymphocytic Leukemia (CLL) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ref …
- 電子分野プラスティックのグローバル市場動向2011-2016（Electronic Plastics – A Global Market Watch, 2011 – 2016）Global Market Watch: Primarily supported by product application; Kitchen Machinery, Audiovisual Equipment and Domestic Machinery the Electronic Plastics market is projected to reach at a value of US$20.9 billion by 2016. Geographical analysis shows the highest Compounded Annual Growth Rate (CAGR) of 10.6% is foreseen from Asia-Pacific region during the analysis period, 2011-2016. The Americas is n …
- 2014年戦略提言：スペインの病院腫瘍マーカー検査市場This new report from Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.&n …
- Raimount Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- 2012Raimount Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Raimount Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- 世界におけるローカルアクセス料金の情報サービス（年間購読）TeleGeography’s Local Access Pricing Service provides in-depth local access price benchmarks and trend analysis for hundreds of metro areas in 146 countries around the world. Data reflect more than 65,000 actual transaction prices. All data are updated twice annually.
- Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Sterilization and Disinfectant Equipment market in the BRICS countries. The report provides value …
- Denbury Resources Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Denbury Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Denbury Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- eコマース（電子商取引）技術のグローバル市場（2014-2018）About e-Commerce Technology Electronic commerce technology, which is generally known as e-Commerce technology, refers to providing software and associated services to facilitate online commerce. e-Commerce software solutions provide a wide range of functionalities other than the basic shopping cart and online catalogues. Today, these software solutions are designed to provide a consistent shopping …
- 自動旅客カウント（APC）及び旅客情報システム（PIS）の世界市場APCs are increasingly used as an alternative to manual passenger counting in North America and Europe to generate and study the ridership trends and patterns. Trains are an important mode of public transport in these region and most APC systems installed in trains are a part of a larger ITS solution. Many new rail vehicles in the region come with an integrated APC system, which is a part of a comp …
- 世界の固体照明（SSL）市場：LED、OLED、PLEDThe increasing demand for energy-saving and environment-friendly lighting technology is driving the growth of the global solid state and other energy efficient lighting systems market. The development of technologies such as optoelectronics has revolutionized the lighting market. Environmental concerns are driving the low-power-consuming lighting systems, and therefore most of the recent developme …
- 電子顕微鏡の世界市場2016-2020About Electron Microscope An electron microscope is a scientific instrument that uses an electron beam to illuminate and enlarge objects under observation. It is mainly used to study miniature and high-density objects such as microchips and find defects in metal sheets used in the steel, automobile, and aerospace industries. Electron microscopes are also used to a large extent in microbiological a …
- 眼科レーザの世界市場2016-2020About the Ophthalmic Lasers Market Medical laser systems are used in various therapeutic areas such as dermatology, ophthalmology, gynecology, and urology. The introduction of a wide range of surgical and aesthetic treatments has led surgeons to perform various medical laser procedures. Advances in medical laser technology have led vendors to develop cost-effective photonic solutions, including be …
- Stone Energy Corporation：石油・ガスバリューチェーン分析レポート2013Stone Energy Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Stone Energy Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Stone Energy Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The …
- SandRidge Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013SandRidge Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary SandRidge Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 耐火材料のグローバル市場動向（2014-2018）About Refractory Materials Refractory materials are used in the refractory lining of furnaces, kilns, incinerators, and reactors. These These materials have a high melting point (greater than 2768 degrees Fahrenheit). They are subjected to various conditions such as high temperature, abrasion and chemical corrosion, slag attack, and chemical reactions when they are used in refractory linings. Henc …
